Merck 8-K 2009
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Merck & Co., Inc.
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(d) Incorporated by reference is a press release issued by Merck & Co., Inc. (the "Company") on February 17, 2009, attached as Exhibit 99.1, announcing the election of Carlos E. Represas to the Company's Board of Directors, effective February 24, 2009. Board Committee assignments for Mr. Represas will be determined at a later date.
Item 9.01 Financial Statements and Exhibits.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.